BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,088 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,935,863 | -8.3% | 117,664 | +17.2% | 0.07% | -23.7% |
Q1 2024 | $4,290,000 | +126.3% | 100,371 | +104.6% | 0.09% | +40.9% |
Q4 2023 | $1,896,000 | -6.3% | 49,054 | -8.5% | 0.07% | -28.3% |
Q3 2023 | $2,024,000 | +30.7% | 53,617 | +57.7% | 0.09% | +4.5% |
Q2 2023 | $1,549,000 | +59.5% | 33,990 | +41.9% | 0.09% | +37.5% |
Q1 2023 | $971,000 | -52.3% | 23,948 | -40.0% | 0.06% | -57.9% |
Q4 2022 | $2,034,000 | -12.8% | 39,908 | -7.8% | 0.15% | -49.3% |
Q3 2022 | $2,332,000 | +110.7% | 43,302 | +151.1% | 0.30% | +87.5% |
Q2 2022 | $1,107,000 | -17.6% | 17,242 | -0.5% | 0.16% | -22.0% |
Q1 2022 | $1,344,000 | -22.0% | 17,331 | -13.7% | 0.20% | -34.3% |
Q4 2021 | $1,724,000 | +578.7% | 20,083 | +579.6% | 0.31% | +24.8% |
Q2 2020 | $254,000 | -18.3% | 2,955 | -37.5% | 0.25% | -1.2% |
Q4 2018 | $311,000 | – | 4,726 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |